SCHEMBL8570432

SCHEMBL8570432

NNC(=O)c1c(F)c(F)c(F)c(F)c1C(=O)NN

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.50
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.41
GAA P10253 1/20 0.40
HSD17B10 Q99714 1/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
KDM4E B2RXH2 2/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7607496 0.94 HTT (0.56) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL7600517 0.82 HTT (0.41) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL28723691 0.78 KDM4E (0.44) HTTSMN1; SMN2LMNATSHRRECQL
SCHEMBL9425021 0.75 CA1 (0.52) HTTLMNARECQLGAACA1
SCHEMBL2645530 0.74 ALDH1A1 (0.42) HTTLMNARECQLGAACA1
SCHEMBL13623386 0.71 HTT (0.54) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL7024101 0.71 HTT (0.48) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL2354218 0.71 HTT (0.54) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL1127907 0.70 CES2 (0.56) HTTLMNAGAACES2CES1
SCHEMBL24687425 0.70 HTT (0.67) HTTPKMSMN1; SMN2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260245-A Iridium metal complex, application thereof and organic electroluminescent device 清华大学 2022-11-01 CN disclosed
EP-3696156-B1 NEW PROCESS FOR THE MANUFACTURE OF FLUOROARYL COMPOUNDS AND DERIVATIVES FUJIAN YONGJING TECH CO LTD (CN) 2022-02-09 EP disclosed
CN-110668912-B Process for the manufacture of fluoroaryl compounds and derivatives thereof 福建永晶科技股份有限公司 2021-04-23 CN disclosed
WO-2020164217-A1 NEW PROCESS FOR MANUFACTURE OF FLUOROARYL COMPOUNDS AND DERIVATIVES FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2020-08-20 WO disclosed
US-20200262770-A1 Process for the Manufacture of Fluoroaryl Compounds and Derivatives FUJIAN YONGJING TECHNOLOGY CO., LTD. (CN) 2020-08-20 US disclosed
EP-3696156-A1 NEW PROCESS FOR THE MANUFACTURE OF FLUOROARYL COMPOUNDS AND DERIVATIVES Fujian Yongjing Technology Co., Ltd. (CN) 2020-08-19 EP disclosed
CN-110668912-A Novel process for producing fluoroaryl compound and derivative thereof 福建永晶科技股份有限公司 2020-01-10 CN disclosed
US-5773236-A FLUORESCENT DYES FOR DETECTION OF ENZYMES FOR METABOLISM IN CELLS MOLECULE PROBES, INC. (US) 1998-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262770-A1 Process for the Manufacture of Fluoroaryl Compounds and Derivatives HNF4A, HDHD5, PFAS HTT 20/4885PKM 1520/4885SMN1; SMN2 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.